Le Lézard
Classified in: Science and technology
Subjects: ACC, MAT

Kindred publishes its Annual and Sustainability Report for 2023


SLIEMA, Malta, March 13, 2024 /PRNewswire/ -- Kindred Group has today published its combined Annual and Sustainability Report for the 2023 financial year. The report can be accessed on Kindred Group's website www.kindredgroup.com.

Kindred Group plc (Kindred) has today published its combined Annual and Sustainability Report for the 2023 financial year. The report provides an introduction to Kindred as a company and the Group's strategy and key value creation drivers.

In his CEO comment, Nils Andén summarises the year and highlights Kindred's focus going forward; "The geopolitical situation across Europe and other parts of the world continues to bring unrest, and during this time we have remained focused and supported each other when needed. Kindred is an extremely successful growth story over the years, partly thanks to our ability to come together as a team, and we remain committed to our purpose of transforming gambling by being a trusted source of entertainment that contributes positively to society."

"At the beginning of 2023, we promised to reach an underlying EBITDA of at least GBP 200 million by the end of the year - a fairly bold target at the time. I am extremely proud of everyone at Kindred as we managed to meet that target. Knowing that we can achieve what we set our mind to, as long as we remain focused and consistent, we have agreed with our Board to deliver an underlying EBITDA of GBP 250 million by the end of 2024", continues Nils Andén.

Kindred's Annual General Meeting will be held on 26 April 2024 at 10.00 CEST in Stockholm, Sweden.

The 2023 Annual and Sustainability Report and Accounts, prepared using the single electronic reporting format specified in the Transparency Directive ESEF Regulation, can be accessed on the Group's website at the following link.

Attached to this Company Announcement is the Directors' Declaration on ESEF Annual Financial Reports.

As part of Kindred's ambition to reduce the company's environmental impact, the Annual and Sustainability Report 2023 is only made available in a digital format.  

This disclosure contains information that Kindred Group is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 13-03-2024 14:00 CET.

Contact: 
For more information:
Alexander Westrell, Director of Communications
[email protected]
+46 73 7071686

Patrick Kortman, Interim CFO
+46 72 3877438
[email protected] 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/kindred-group/r/kindred-publishes-its-annual-and-sustainability-report-for-2023,c3945235

The following files are available for download:

https://mb.cision.com/Main/824/3945235/2666598.pdf

Kindred Group Annual and Sustainability Report 2023

https://mb.cision.com/Public/824/3945235/98e983389b15325f.pdf

Directors' Declaration

https://mb.cision.com/Public/824/3945235/9e0d2cc47292587d.pdf

Kindred publishes its Annual and Sustainability Report for 2023

https://news.cision.com/kindred-group/i/kindred-ara2023-press-release,c3277922

Kindred ARA2023 press release

 

SOURCE Kindred Group


These press releases may also interest you

at 14:13
AdvoLogix®, a leading innovator in cloud-based legal management, is revolutionizing how legal teams work. AdvoLogix's all-encompassing platform, built entirely on Salesforce, seamlessly integrates Spend Management, Matter Management, Document...

at 14:05
Bruker Corporation today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the "928 Patent") in Germany (case 3 Ni 20/22). NanoString is now a...

at 14:05
GLOBAL RELEASE ? NOT INTENDED FOR DISTRIBUTION IN THE UK LEO Pharma A/S, a global leader in medical dermatology, today announces positive results from the Enstilar® phase 3 trial in China in adult patients living with stable plaque psoriasis. The...

at 14:04
Fzata, Inc. is pleased to announce successful completion of a current good manufacturing practices (cGMP) run of lead drug, FZ002, with sufficient drug quantities to support the phase 1 first-in-human (FIH) clinical study....

at 14:02
Sharp Token, the highly anticipated "Learn2Earn" and "Spend2Grow" utility token officially launches May 7th on the Coinstore exchange. The Sharp Token is a utility reward token focused on tech education, learning, and community member growth....

at 14:02
BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada. Situated in downtown Toronto,...



News published on and distributed by: